NCT04335227

Brief Summary

Weight loss and lifestyle modifications are much required in women with Polycystic ovarian syndrome (PCOS). Yoga has gained great importance as an alternate medicine in recent years which is helpful in lifestyle modifications. Weight loss can be achieved by regular aerobic activity. In recent years, excessive production of anti-mullerian hormone (AMH) has been considered as the etiology of PCOS. AMH is also emerging as a diagnostic and screening tool for PCOS. Effect of yoga therapy on adolescent girls have proved to be effective. But, researches on young women undergoing yoga therapy and combined effect of aerobic exercise and yoga therapy are still lacking. Hence, the investigators aimed t o establish the benefits of yoga therapy and aerobic exercise on Anti-Mullerian Hormone and other biochemical markers in young women with polycystic ovary syndrome.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
128

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2021

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 27, 2020

Completed
10 days until next milestone

First Posted

Study publicly available on registry

April 6, 2020

Completed
1.6 years until next milestone

Study Start

First participant enrolled

November 14, 2021

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 12, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 14, 2023

Completed
Last Updated

August 24, 2021

Status Verified

August 1, 2021

Enrollment Period

1.3 years

First QC Date

March 27, 2020

Last Update Submit

August 22, 2021

Conditions

Keywords

Yoga therapyAerobic exercise trainingAerobic exerciseAerobic trainingPolycystic ovary syndromeAntimullerian hormone

Outcome Measures

Primary Outcomes (1)

  • Serum Anti-Mullerian hormone Concentration

    Serum Anti-Mullerian hormone will be determined by blinded lab technician

    Change from Baseline Serum Anti-Mullerian hormone Concentration at 12 weeks

Secondary Outcomes (11)

  • Antral follicle count

    Change from Baseline Antral follicle count at 12 weeks

  • Serum Follicle-stimulating hormone Concentration

    Change from Baseline Serum Follicle-stimulating hormone Concentration at 12 weeks

  • Serum Luteinizing hormone Concentration

    Change from Baseline Serum Luteinizing hormone Concentration at 12 weeks

  • Serum Testosterone Concentration

    Change from Baseline Serum Testosterone Concentration at 12 weeks

  • Serum Prolactin Concentration

    Change from Baseline Serum Prolactin Concentration at 12 weeks

  • +6 more secondary outcomes

Study Arms (4)

Yoga therapy group

EXPERIMENTAL

Structured yoga therapy program for 60 minutes six days per week for 12 weeks and nutritional management uniquely prepared by dietitian

Other: Structured yoga therapy program

Aerobic exercise group

EXPERIMENTAL

Aerobic training of moderate intensity for 30-60 minutes six days per week for 12 weeks and nutritional management uniquely prepared by dietitian

Other: Aerobic exercise training program

Combined yoga therapy and aerobic exercise group

EXPERIMENTAL

Combined yoga therapy for three days and vigorous aerobic exercise program for three days with nutritional management uniquely prepared by dietitian

Other: Combined yoga and aerobic training program

Control group

ACTIVE COMPARATOR

Nutritional management uniquely prepared by dietitian

Other: Nutritional management

Interventions

Structured yoga therapy prepared according to traditional yoga scriptures of Patanjali yoga sutras will be administered to 32 females with PCOS. The structured yoga therapy which includes, Surya Namaskara (Sun Salutation) and asanas performed in four positions, standing, sitting, supine and prone for total duration of 60 minutes. In addition to this, they will be asked to undergo nutritional management uniquely prepared by dietitian

Yoga therapy group

Thirty two females with PCOS in aerobic exercise (AE) group will be subjected to aerobic training of moderate intensity for 30-60 minutes six days per week for 12 weeks, in the light of guidelines framed by American College of Sports Medicine (ACSM). Aerobic exercise volume for each female recruited will be set at greater than 500 and up to 1000 MET-min/week, which will be approximately equal to 1000 kcal/week. They will be made sure that they exercise for minimum duration of 150 min/week and thereby covering 5400 to 7900 steps/day in pedometer readings. In addition to this, they will be asked to undergo nutritional management uniquely prepared by dietitian

Aerobic exercise group

Thirty two females with PCOS in combined yoga therapy and aerobic exercise (cYTAE) group will be subjected to three days of structured yoga therapy and three days of aerobic training of vigorous intensity. In addition to this, they will be asked to undergo nutritional management uniquely prepared by dietitian

Combined yoga therapy and aerobic exercise group

Thirty two females with PCOS will be asked to undergo only nutritional management uniquely prepared by dietitian

Control group

Eligibility Criteria

Age18 Years - 30 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsFemale with polycystic ovarian syndrome
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Female in age between 18 and 30 years
  • Female with at least two-thirds of the features listed in the Rotterdam criteria for PCOS were included in the study
  • Oligomenorrhea or amenorrhea (an absence of menstruation for 45 or more days and/or fewer than 9 menses per year)
  • Hyperandrogenism (a score of 8 or higher ( ≥ 8) on the modified Ferriman-Gallwey scale)
  • Polycystic ovaries (presence of more than 12 cysts \< 9 mm in diameter in single ovary, usually combined with an ovarian volume \> 10 ml

You may not qualify if:

  • On regular hormonal treatment
  • Oral contraceptives
  • Insulin-sensitizing agents in the previous 6 weeks
  • Smoking in less than 48 hours
  • Alcohol in less than 48 hours
  • History of thyroid abnormalities
  • Practicing regular yoga asanas and pranayama
  • Regular aerobic training program

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Maharishi Markandeshwar Hospital, Mullana

Ambāla, Haryana, 133207, India

Location

Maharishi Markandeshwar Medical College & Hospital, Kumarhatti

Solan, Himachal Pradesh, 173229, India

Location

MeSH Terms

Conditions

Polycystic Ovary Syndrome

Interventions

Diet

Condition Hierarchy (Ancestors)

Ovarian CystsCystsNeoplasmsOvarian DiseasesAdnexal DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesGonadal DisordersEndocrine System Diseases

Intervention Hierarchy (Ancestors)

Nutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Officials

  • Asir J Samuel, MPT, PhD

    Maharishi Markandeshwar Institute of physiotherapy and Rehabilitation, Mullana

    PRINCIPAL INVESTIGATOR
  • Unmesh Santpur, MBBS, MD

    Maharishi Markandeshwar Institute of Medical Sciences and Research, Mullana

    STUDY DIRECTOR
  • Kiranjeet Kaur, MBBS, MD

    Maharishi Markandeshwar Medical College & Hospital, Solan

    STUDY CHAIR

Central Study Contacts

Asir J Samuel, MPT, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Lab technician who test the blood samples of the female with Polycystic Ovary Syndrome (PCOS) will be blinded to the trial
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Recruited female with PCOS with 128 female with PCOS will be randomly divided into four parallel groups, yoga therapy (YT) group, aerobic exercise (AE) group, combined YT and AE (cYTAE) group and control group
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

March 27, 2020

First Posted

April 6, 2020

Study Start

November 14, 2021

Primary Completion

March 12, 2023

Study Completion

April 14, 2023

Last Updated

August 24, 2021

Record last verified: 2021-08

Data Sharing

IPD Sharing
Will not share

Not now

Locations